Now the virus has spread outside of the DRC, prompting the WHO to call on public health experts to advise ‘on whether the outbreak represents a public health emergency of international concern.’ ...

comments on the extension of the MPox Public Health Emergency of International Concern (PHEIC) by WHO. The Director General of WHO has extended the PHEIC declaration for MPox epidemic according to a ...

In justifying the United States' rejection of updates to global health regulations, the Department of Health and Human ...

The mpox outbreak is still a public health emergency, the World Health Organization said on Monday, with the health body's director-general issuing a revised set of temporary recommendations. The ...

This will be a randomized clinical trial comparing NV-387 treatment with the Standard of Care, to evaluate the dosing regimen for NV-387, the safety and tolerability of the dosing regimen in MPox ...

The World Health Organisation (WHO) has reiterated that Mpox -- formerly known as monkeypox -- remains a Public Health Emergency of International Concern (PHEIC), as the virus continues to resurface ...

It expanded the scope of the regulations beyond a few specific diseases to include any public health emergency of international concern — biological, chemical, radiological, or nuclear in origin.

In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox. The current outbreak in Africa is driven mainly by the clade I variant ...

On Jan. 30, 2020, Tedros Adhanom Ghebreyesus, the director general of the WHO, announced a “public health emergency of international concern” in response to the advancing COVID-19 crisis.

This will be a randomized clinical trial comparing NV-387 treatment with the Standard of Care, to evaluate the dosing regimen for NV-387, the safety and tolerability of the dosing regimen in MPox ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American: NNVC ) (the "Company"), and a clinical stage, leading global pioneer in ...